Gomisin D is an orally active lignan that binds to PDGFRbeta with a Kd of 10 µM. By targeting PDGFRbeta to regulate signaling pathways, Gomisin D inhibits the activation and proliferation of hepatic stellate cells and promotes their apoptosis, thereby ameliorating hepatic fibrosis. Gomisin D exhibits multiple activities such as photoprotection, antimelanogenesis, antioxidant effects, and hypoglycemic activity. Gomisin D can be used in studies related to diabetes, Alzheimers disease, and hepatic fibrosis[1][2][3].
Molekulargewicht:
530.56
Reinheit:
99.56
CAS Nummer:
[60546-10-3]
Formel:
C28H34O10
Target-Kategorie:
Akt,Apoptosis,COX,ERK,Interleukin Related,p38 MAPK,PDGFR,Reactive Oxygen Species (ROS),Tyrosinase,UGT
Anwendungsbeschreibung:
MCE Product type: Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten